Ausdal Financial Partners, Inc. Sorrento Therapeutics, Inc. Call Options Transaction History
Ausdal Financial Partners, Inc.
- $848 Million
- Q1 2024
Call Options
2 transactions
Others Institutions Holding SRNE
# of Institutions
15Shares Held
5.51MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Lattice Capital Management, LLC51.8KShares$17,0940.02% of portfolio
-
Klcm Advisors, Inc.30KShares$9,9000.0% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...